MGMT and neoplasm: The improved therapeutic outcome observed with the combination of temozolomide and capecitabine may be due to its ability to decrease O6-methylguanine DNA methyltransferase (MGMT) levels in tumor cells, thereby boosting the alkylating effectiveness of temozolomide [67].